A novel, potent, highly selective inhibitor of c-Met kinase, Simm559, inhibits c-Met-dependent neoplastic phenotypes in vitro and in vivo.

CORC > 上海药物研究所 > 中国科学院上海药物研究所 > 药理学第一研究室

	A novel, potent, highly selective inhibitor of c-Met kinase, Simm559, inhibits c-Met-dependent neoplastic phenotypes in vitro and in vivo.
	Ai, Jing; Zhan, ZhengSheng; Wang, Ying; Chen, Fang; Peng, Xia; Chen, Yi; Ji, Yinchun; Ding, Jian; Geng, Meiyu; Duan, Wenhu
	2013-11
卷号	12
期号	11
DOI	10.1158/1535-7163.TARG-13-B285
会议录	MOLECULAR CANCER THERAPEUTICS
会议录出版者	AMER ASSOC CANCER RESEARCH
文献子类	Meeting Abstract
语种	英语
WOS研究方向	Oncology
WOS记录号	WOS:000209496800450
内容类型	会议论文
源URL	[http://119.78.100.183/handle/2S10ELR8/266167]
专题	药理学第一研究室
作者单位	Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China
推荐引用方式 GB/T 7714	Ai, Jing,Zhan, ZhengSheng,Wang, Ying,et al. A novel, potent, highly selective inhibitor of c-Met kinase, Simm559, inhibits c-Met-dependent neoplastic phenotypes in vitro and in vivo.[C]. 见:.